Benzalkonium chlorides (BACs) have been of environmental concern due to their widespread use and potential harm. However, challenges arise in defining and controlling the exposure concentration () in aquatic toxicity tests involving BACs with a long alkyl chain (i.e., #C > 14). To address this, a novel passive dosing method was introduced in the 48 h-acute ecotoxicity test on and compared to the conventional solvent-spiking method in terms of stability and toxicity results. Among 13 sorbent materials tested for their sorption capacity, poly(ether sulfone) (PES) membrane was an optimal passive dosing reservoir, with equilibrium desorption of BACs to water achieved within 24 h. The of BACs remained constant in both applied dosing methods during the test period. However, the in solvent-spiking tests was lower than the nominal concentration for long-chain BACs, particularly at low exposure concentrations. Notably, the solvent-spiking tests indicated that the toxicity of BACs increased with alkyl chain length from C6 to 14, followed by a decline in toxicity from C14 to 18. In contrast, the passive dosing method displayed similar or slightly increasing toxicity levels of BACs from C14 to C18, indicating higher toxicity of C16 and C18-BACs than that inferred by the solvent spiking test. These findings emphasize the potential of applying this innovative passive dosing approach in aquatic toxicity tests to generate reliable and accurate toxicity data and support a comprehensive risk assessment of cationic surfactants.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.est.4c03027 | DOI Listing |
Alzheimers Dement
December 2024
The Florey Institute of Neuroscience and Mental Health, Melbourne, VIC, Australia.
Background: Monoclonal antibodies have emerged as a leading therapeutic agent for the treatment of disease, including Alzheimer's disease. Such antibodies, however, are expensive and timely to produce and require frequent dosing regimens to ensure disease-modifying effects. Synthetic in vitro-transcribed mRNA encoding antibodies presents a promising alternative to conventional passive immunotherapy and overcomes the need to generate recombinant antibodies.
View Article and Find Full Text PDFFood Funct
January 2025
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) - Raebareli. Transit campus, Bijnour-sisendi Road, Sarojini Nagar, Lucknow-226002, Uttar Pradesh, India.
Curr Issues Mol Biol
December 2024
Department of Anatomy, Histology and Embryology, Medical Faculty, Medical University Plovdiv, 4002 Plovdiv, Bulgaria.
Epilepsy is a common brain function disorder. The present study aims to evaluate the long-term effect of perampanel (PRM) and lacosamide (LCM), administered singly in a high-dose or in a low-dose combination of both, on comorbid anxiety, cognitive impairment, BDNF, and Cyclin D1 hippocampal expression in an experimental model of temporal lobe epilepsy with lithium-pilocarpine. PRM (3 mg/kg, p.
View Article and Find Full Text PDFProbl Radiac Med Radiobiol
December 2024
State Institution «O.M. Marzіeiev Institute for Public Health of the National Academy of Medical Sciences of Ukraine», 50 Hetman Pavlo Polubotok Str., Kyiv, 02094, Ukraine.
Objective: assessment of probable exposure levels from radon and NORM in workplaces within the context of justi fying radiation protection plans in an existing exposure situation.
Materials And Methods: Materials regarding the assessment of naturally occurring radioactive material (NORM) con tent in tailing from mining and processing industries in Ukraine and assessments of contamination levels of industri al sites of oil and gas enterprises were used for estimating the probable range of effective doses (ED) of workers fromNORM at industrial enterprises. These materials were obtained as a result of research conducted by specialists from theRadiation Protection Laboratory of the State Institution «O.
Med Phys
December 2024
Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Background: A passive dosimeter framework for the measurement of dose in carbon ion beams has yet to be characterized or implemented for regular use.
Purpose: This work determined the dose calculation correction factors for absorbed dose in thermoluminescent dosimeters (TLDs) in a therapeutic carbon ion beam. TLD could be a useful tool for remote audits, particularly in the context of clinical trials as new protocols are developed for carbon ion radiotherapy.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!